Valuation West Pharmaceutical Services, Inc.
Stocks
WST
US9553061055
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 346.56 USD | +1.81% |
|
+5.67% | +25.96% |
Company Valuation: West Pharmaceutical Services, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 34,744 | 17,424 | 26,053 | 23,723 | 19,795 | 24,484 | - | - |
| Change | - | -49.85% | 49.53% | -8.95% | -16.56% | 23.69% | - | - |
| Enterprise Value (EV) 1 | 34,744 | 16,738 | 25,406 | 23,441 | 19,206 | 23,742 | 23,457 | 23,142 |
| Change | - | -51.82% | 51.78% | -7.74% | -18.07% | 23.62% | -1.2% | -1.34% |
| P/E | 54.1x | 30.4x | 44.7x | 49x | 40.5x | 41.2x | 36.1x | 32.4x |
| PBR | 14.9x | 6.5x | 8.98x | 8.83x | 5.95x | 7.61x | 6.68x | 5.87x |
| PEG | - | -2.8x | 23.04x | -3.2x | 27.09x | 1.7x | 2.6x | 2.9x |
| Capitalization / Revenue | 12.3x | 6.04x | 8.83x | 8.2x | 6.44x | 7.35x | 6.92x | 6.46x |
| EV / Revenue | 12.3x | 5.8x | 8.61x | 8.1x | 6.25x | 7.13x | 6.63x | 6.11x |
| EV / EBITDA | 39.3x | 19x | 30.7x | 32.2x | 24.2x | 25.7x | 23.1x | 20.5x |
| EV / EBIT | 45.6x | 22x | 36.8x | 40.9x | 30.9x | 32x | 28.5x | 25.2x |
| EV / FCF | 105x | 38.1x | 61.3x | 84.8x | 41x | 53.3x | 45.7x | 40.3x |
| FCF Yield | 0.95% | 2.63% | 1.63% | 1.18% | 2.44% | 1.88% | 2.19% | 2.48% |
| Dividend per Share 2 | 0.69 | 0.74 | 0.78 | 0.82 | 0.85 | 0.896 | 0.9681 | 1.137 |
| Rate of return | 0.15% | 0.31% | 0.22% | 0.25% | 0.31% | 0.26% | 0.28% | 0.33% |
| EPS 2 | 8.67 | 7.73 | 7.88 | 6.69 | 6.79 | 8.42 | 9.606 | 10.68 |
| Distribution rate | 7.96% | 9.57% | 9.9% | 12.3% | 12.5% | 10.6% | 10.1% | 10.6% |
| Net sales 1 | 2,832 | 2,887 | 2,950 | 2,893 | 3,074 | 3,331 | 3,538 | 3,789 |
| EBITDA 1 | 884.7 | 882.6 | 827.9 | 728.2 | 793.8 | 923.1 | 1,018 | 1,131 |
| EBIT 1 | 762.4 | 762 | 690.6 | 572.8 | 622.4 | 741.3 | 822.8 | 918.6 |
| Net income 1 | 661.8 | 585.9 | 593.4 | 492.7 | 493.7 | 604.7 | 685.6 | 754.9 |
| Net Debt 1 | - | -685.4 | -647.1 | -282 | -588.5 | -741.5 | -1,026 | -1,342 |
| Reference price 2 | 469.01 | 235.35 | 352.12 | 327.56 | 275.14 | 346.56 | 346.56 | 346.56 |
| Nbr of stocks (in thousands) | 74,080 | 74,033 | 73,990 | 72,422 | 71,943 | 70,648 | - | - |
| Announcement Date | 2/17/22 | 2/16/23 | 2/15/24 | 2/13/25 | 2/12/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 41.16x | 7.13x | 25.72x | 0.26% | 24.48B | ||
| 23.45x | 3.46x | 13.01x | 2.73% | 162B | ||
| 18.38x | 3.2x | 11.28x | 3.68% | 103B | ||
| 15.78x | 0.18x | 11.32x | 0.83% | 55.83B | ||
| 33.02x | 8.02x | 20.98x | 1.22% | 54.05B | ||
| 37.72x | 3x | 10.31x | 2.54% | 41.71B | ||
| 36.16x | 1.33x | 11.73x | 0.22% | 31.94B | ||
| 28.05x | 4.99x | 15.91x | -.--% | 26.49B | ||
| 23.17x | 3.39x | 12.19x | 1.25% | 20.52B | ||
| 23.66x | 3.02x | 12.32x | 1.37% | 20.02B | ||
| Average | 28.05x | 3.77x | 14.48x | 1.41% | 54.05B | |
| Weighted average by Cap. | 25.52x | 3.59x | 13.68x | 2.05% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- WST Stock
- Valuation West Pharmaceutical Services, Inc.
Select your edition
All financial news and data tailored to specific country editions
















